Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 9/20 | 0.43 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5068634 | 1.00 | FDPS (0.43) | FDPSGGPS1SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL5066598 | 1.00 | FDPS (0.43) | FDPSGGPS1SMN1; SMN2LMNAALDH1A1 | |
| SCHEMBL16074821 | 0.97 | FDPS (0.45) | FDPSGGPS1LMNAALDH1A1HSD17B10 | |
| SCHEMBL12491942 | 0.97 | FDPS (0.45) | FDPSGGPS1LMNAALDH1A1HSD17B10 | |
| SCHEMBL16074785 | 0.97 | FDPS (0.45) | FDPSGGPS1LMNAALDH1A1HSD17B10 | |
| SCHEMBL16074826 | 0.97 | FDPS (0.45) | FDPSGGPS1LMNAALDH1A1HSD17B10 | |
| SCHEMBL9130408 | 0.97 | FDPS (0.45) | FDPSGGPS1LMNAALDH1A1HSD17B10 | |
| SCHEMBL12491913 | 0.97 | FDPS (0.45) | FDPSGGPS1LMNAALDH1A1HSD17B10 | |
| SCHEMBL9130650 | 0.97 | FDPS (0.45) | FDPSGGPS1LMNAALDH1A1HSD17B10 | |
| SCHEMBL16074775 | 0.97 | FDPS (0.45) | FDPSGGPS1LMNAALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250369024-A1 | Acyloin Condensation Reactions, Enzymes, and Products Thereof | MOJIA BIOTECH PTE LTD (SG) | 2025-12-04 | — | — | US | claimed |
| EP-4649157-A2 | ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF | Mojia Biotech Pte. Ltd. (SG) | 2025-11-19 | — | — | EP | claimed |
| WO-2024150067-A2 | ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF | MOJIA BIOTECH PTE. LTD. (SG) | 2024-07-18 | — | — | WO | claimed |
| US-20260078416-A1 | ORTHOGONAL METABOLIC FRAMEWORK FOR ONE-CARBON UTILIZATION | MOJIA BIOTECH PTE LTD (SG) | 2026-03-19 | — | — | US | disclosed |
| US-20250369024-A1 | Acyloin Condensation Reactions, Enzymes, and Products Thereof | MOJIA BIOTECH PTE LTD (SG) | 2025-12-04 | — | — | US | disclosed |
| EP-4649157-A2 | ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF | Mojia Biotech Pte. Ltd. (SG) | 2025-11-19 | — | — | EP | disclosed |
| WO-2024150067-A2 | ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF | MOJIA BIOTECH PTE. LTD. (SG) | 2024-07-18 | — | — | WO | disclosed |
| US-20240229047-A1 | CARBOXYLIC ACID PLATFORM FOR FUEL AND CHEMICAL PRODUCTION AT HIGH CARBON AND ENERGY EFFICIENCY | MOJIA BIOTECH PTE LTD (SG) | 2024-07-11 | — | — | US | disclosed |
| EP-4388104-A2 | ORTHOGONAL METABOLIC FRAMEWORK FOR ONE-CARBON UTILIZATION | Mojia Biotech Pte. Ltd. (SG) | 2024-06-26 | — | — | EP | disclosed |
| CN-118251496-A | Carboxylic acid platforms for high carbon and energy efficient fuel and chemical production | 摩珈生物科技有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-118139983-A | Orthogonal metabolism framework for one-carbon utilization | 摩珈生物科技有限公司 | 2024-06-04 | — | — | CN | disclosed |
| WO-1997003170-A1 | CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | disclosed |
| WO-1997003169-A1 | CONCENTRATED, STABLE FABRIC SOFTENING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-30 | — | — | WO | disclosed |
| EP-0713851-A1 | Process of producing hydroxyalkanal | NIPPON SHOKUBAI CO., LTD. (JP) | 1996-05-29 | — | — | EP | disclosed |
| US-5419817-A | Osmium tetroxide catalyst; preparing hydroxycarbonyl compounds from enol ether or vinyl halide | SEPRACOR INC. (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0643781-A4 | ELECTROCATALYTIC ASYMMETRIC DIHYDROXYLATION OF OLEFINIC COMPOUNDS. | — | 1995-04-26 | — | — | EP | disclosed |
| EP-0643781-A1 | ELECTROCATALYTIC ASYMMETRIC DIHYDROXYLATION OF OLEFINIC COMPOUNDS | SEPRACOR, INC. (US) | 1995-03-22 | — | — | EP | disclosed |
| US-5302257-A | Preparing optically active glycols using catalyst complex of osmium tetroxide and chiral oxidation resistant tertiary amine, employing secondary oxidant to generate osmium tetroxide, electrolytically regenerating secondary oxidant | SEPRACOR, INC. (US) | 1994-04-12 | — | — | US | disclosed |
| WO-1993017150-A1 | ELECTROCATALYTIC ASYMMETRIC DIHYDROXYLATION OF OLEFINIC COMPOUNDS | SEPRACOR, INC. (US) | 1993-09-02 | — | — | WO | disclosed |
| EP-0063337-A1 | 13-Oxa prostacyclin derivatives, their preparation and pharmaceutical compositions | CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) | 1982-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078416-A1 | ORTHOGONAL METABOLIC FRAMEWORK FOR ONE-CARBON UTILIZATION | COASY, HACL2, ACSL1 | FDPS 19/4885GGPS1 404/4885SMN1; SMN2 4253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.